ReviewBritish journal of clinical pharmacology2015
Social media and pharmacovigilance: A review of the opportunities and challenges.
Review in British journal of clinical pharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
58 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Factors associated with underreporting of adverse drug reactions by patients: a systematic review.International journal of clinical pharmacy · 2023Pooled it
- Twitter as a Tool for Health Research: A Systematic Review.American journal of public health · 2017Pooled it
- Self-Reported Adverse Effects Among Social Media Users Taking Nonapproved Retatrutide.JAMA network open · 2026Article
- Metabolic Disturbances Associated with Beta-Blocker Therapy: New Insights from a Large-Scale Pharmacovigilance Study.Pharmaceuticals (Basel, Switzerland) · 2026Article
- Self-Reported Health Outcomes in Metabolic Health YouTube Comments: Cross-Sectional Study and Rule-Based Natural Language Processing Framework Development and Validation.Journal of medical Internet research · 2026Observational
- Which social media platforms facilitate monitoring the opioid crisis?PLOS digital health · 2025Article
- Investigating the Benefit-Risk Profile of Drugs: From Spontaneous Reporting Systems to Real-World Data for Pharmacovigilance.Methods in molecular biology (Clifton, N.J.) · 2025Article
- An innovative method to strengthen evidence for potential drug safety signals using Electronic Health Records.Journal of medical systems · 2024Article
- Using Social Media as a Source of Real-World Data for Pharmaceutical Drug Development and Regulatory Decision Making.Drug safety · 2024Article
- Revisiting Disproportionality: Prescription-Adjusted and TF-IDF-Inspired Metrics for Post-Market ADR Detection.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2024Article
- Leveraging patient experience data to guide medicines development, regulation, access decisions and clinical care in the EU.Frontiers in medicine · 2024Review
- Pharmacovigilance and Adverse Drug Reaction Reporting among the General Public in Lithuania: A Cross-Sectional Study.Healthcare (Basel, Switzerland) · 2023Article
- #ChronicPain: Automated Building of a Chronic Pain Cohort from Twitter Using Machine Learning.Health data science · 2023Article
- Temporal Trends in Perceptions of Anti-tumor Necrosis Factor Risks and Benefits in an Online Community of Patients With Crohn's Disease.Gastro hep advances · 2023Article
- Sample Bias in Web-Based Patient-Generated Health Data of Dutch Patients With Gastrointestinal Stromal Tumor: Survey Study.JMIR formative research · 2022Article
- A Narrative Review of Adverse Event Detection, Monitoring, and Prevention in Indian Hospitals.Cureus · 2022Review
- Biases in using social media data for public health surveillance: A scoping review.International journal of medical informatics · 2022Article
- Automated gathering of real-world data from online patient forums can complement pharmacovigilance for rare cancers.Scientific reports · 2022Article
- Artificial Intelligence-Based Pharmacovigilance in the Setting of Limited Resources.Drug safety · 2022Review
- Comparison of Online Patient Reviews and National Pharmacovigilance Data for Tramadol-Related Adverse Events: Comparative Observational Study.JMIR public health and surveillance · 2022Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Adverse drug reactions come at a considerable cost on society. Social media are a potentially invaluable reservoir of information for pharmacovigilance, yet their true value remains to be fully understood. In order to realize the benefits social media holds, a number of technical, regulatory and ethical challenges remain to be addressed. We outline these key challenges identifying relevant current research and present possible solutions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.